Condition: Non-Alcoholic Fatty Liver Disease · Gallstone Disease · Sponsor: Pontificia Universidad Catolica de Chile
Prevention of non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease (CVD) through lifestyle intervention (MAUCO+) is a clinical trial that aims to improve sarcopenia, aerobic capacity, body composition, and lipid profile, insulin resistance, cardiovascular risk, NAFLD, and maintain a healthier lifestyle. Through the implementation of physical activity and nutritional programs.
This description comes directly from the study's public registry record.
Laura A Huidobro, PhD · +56 9 9219 6618 · leahuidobro@gmail.com
Catterina Ferreccio, MD · +56 9 95788658 · catferre@gmail.com
Always discuss trial participation with your own doctor first.
| Centro MAUCO+ | Molina, Maule Region, Chile | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05618626